Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
NVIDIA Beats Earnings Expectations on Strong Gaming, Data Center Revenue
Chipmaker NVIDIA easily beat its third quarter fiscal 2022 earnings expectations, reporting earnings per share of $1.17 on revenue of $7.1 billion, thanks to success in its gaming and data center divisions. The company is also poised for potential success as tech giants like Facebook and Microsoft push forward with metaverse projects and technology. Daniel Newman, Founding Partner and Principal Analyst at Futurum Research, joins Cheddar News' Closing Bell to discuss NVIDIA's earnings results, chipmaker competition, and more.
Load More